Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
97 hedge funds and large institutions have $277M invested in Intersect ENT, Inc in 2015 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 6 closing their positions.
717% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 6
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
130% more capital invested
Capital invested by funds: $120M → $277M (+$156M)
108% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 13
80% more funds holding
Funds holding: 54 → 97 (+43)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$28.1M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$7.67M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$6.88M |
| 4 |
JP Morgan Chase
New York
|
+$6.23M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
+$5.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$8M |
| 2 |
NVPX
Norwest Venture Partners XI
Palo Alto,
California
|
-$6.86M |
| 3 |
Morgan Stanley
New York
|
-$2.34M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.07M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$993K |
XENT Hedge Fund Activity: Q1 2015 in Review
97 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2015, worth a combined $277M — up 130% from $120M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new XENT positions and 6 closed out — a net gain of 43 holders — while 27 added to existing stakes and 13 trimmed.
The largest buyer was Jennison Associates, adding an estimated $28.1M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $8M sold.
- 97 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2015, up from 54 in Q4 2014.
- Funds reported $277M of Intersect ENT, Inc stock for Q1 2015, up 130% quarter-over-quarter.
- 49 funds opened new Intersect ENT, Inc positions in Q1 2015 and 6 closed out, a net change of +43 holders.
- The largest Intersect ENT, Inc buyer in Q1 2015 was Jennison Associates, an estimated $28.1M added.
- The largest Intersect ENT, Inc seller in Q1 2015 was Novo Holdings A/S, an estimated $8M sold.
Based on aggregated 13F filings for Q1 2015.